Educational Podcasts for GPO Members
The education you want - wherever you want.
GPO Legislative Townhall August 2023: Part 8
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.
Our next episode will feature information on politics and policy, and physician payment issues. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.
GPO Legislative Townhall: Part 7
GPO Legislative Townhall: Part 6
GPO Legislative Townhall: Part 5
GPO Legislative Townhall: Part 4
GPO Legislative Townhall: Part 3
GPO Legislative Townhall: Part 2
GPO Legislative Townhall: Part 1
Biosimilar Series: Part 5
Biosimilar Series: Part 4
Biosimilar Series: Part 3
Biosimilar Series: Part 2
Biosimilar Series: Part 1
Biomarkers: Emerging Targets and Technologies
Biomarker Testing: A Closer Look at When, Who, and How to Test
Germline Genetic Testing
In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.
The content and information contained in this podcast is sponsored by Invitae. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of AmerisourceBergen or Invitae.
Biomarkers 101: Basics of Biomarker Testing
Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML
Novel Agents and Toxicity Management 101
Using AI Clinical Decision Support to Manage Cancer Complexity
Paradigms, Policy and Pharmaco-genomics
Clinical trials: How has precision medicine elevated the role of community oncology?
Off Our Chests: A Discussion with Dr. John and Liza Marshall
Precision Medicine Evolution, Pt 2
Precision Medicine Evolution, Pt 1
A Conversation with Annexus Health
Precision Medicine Center